BridgeMD
New treatment option for Painful Menstruation
Official title Impact of Virtual Reality on Painful Menstruation
ClinicalTrials.gov ID: NCT06961396
What this study is testing
- What it's testing
- To investigate the effect of virtual reality on painful menstruation in adolescent female
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 20, women only. Healthy volunteers may be eligible.
You may be able to join if
- age from 16 to 22 year
- cases of primary dysmenorrhea
- Normal body mass index (20-25)
You likely can't join if
- cases with polycystic ovarian syndrome
- Obese female or body mass index more than 25
- severe bleeding with menstruation
- cases with low back pain due to orthopedic origin like disc herniation or spinal malalignment
The study team makes the final eligibility decision.
Where it's taking place
- Ismailia, Egypt
- Amman, Jordan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 13 years to 20 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ismailia, Egypt; Amman, Jordan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.